CD19 and B-cell neoplasm: Despite these limitations, our study serves as proof‐of‐principle of the utility and advantages of interphase FISH analysis performed on CD19‐selected cells over non‐selected cells for the detection of recurrent cytogenetic aberrations in B‐cell neoplasms in the post‐therapy setting.